EBS vs GL · rev $1.04B vs P/E 10, $10.26B cap
Emergent Biosolutions Inc (EBS) versus Globe Life Inc (GL) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Globe Life Inc (GL) is a insurance - life company listed on US.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
GL does not have a complete income-statement cache yet.
EBS currently screens at market cap $416.4M. GL currently screens at market cap $10.26B and trailing P/E 10.1.
Not investment advice. Open the EBS and GL stock pages for the full models.
Not investment advice.